PayPal Faces Lawsuit Over Misleading Investor Claims
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 18 2026
0mins
Should l Buy PYPL?
Source: PRnewswire
- Lawsuit Background: Hagens Berman has filed a securities class action against PayPal Holdings, Inc., alleging that management misled investors during the period from February 25, 2025, to February 2, 2026, resulting in significant investor losses.
- Leadership Change: The lawsuit follows an unexpected leadership change and the abrupt withdrawal of long-term financial targets, which has notably shaken investor confidence and disrupted the company's growth narrative.
- Legal Allegations: The complaint alleges that PayPal violated federal securities laws throughout the class period, particularly regarding misleading claims about 'Branded Checkout,' highlighting a significant disconnect between the company's public optimism and its internal operational reality.
- Investor Action: Investors are urged to apply to be lead plaintiffs by April 20, 2026, to seek recovery in the lawsuit, indicating that the legal risks faced by the company could negatively impact its stock price.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PYPL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PYPL
Wall Street analysts forecast PYPL stock price to rise
29 Analyst Rating
6 Buy
19 Hold
4 Sell
Hold
Current: 43.590
Low
51.00
Averages
72.86
High
100.00
Current: 43.590
Low
51.00
Averages
72.86
High
100.00
About PYPL
PayPal Holdings, Inc. offers a technology platform. The Company’s products are designed to enable digital payments and simplify commerce experiences for consumers and merchants to make selling, shopping, and sending and receiving money simple, personalized, and secure, online or offline, including mobile. It provides consumers with a digital wallet that enables them to send payments to merchants securely using a variety of funding sources, which include a bank account, a PayPal or Venmo account balance, its consumer credit products, a credit card, a debit card, certain cryptocurrencies, or other stored value products. It operates a global, two-sided network at scale that connects consumers and merchants with 434 million active accounts across approximately 200 markets. Its brands include PayPal, Braintree, Venmo, Xoom, Hyperwallet, PayPal Zettle, PayPal Honey, and Paidy. It offers financing products through the PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL).
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Affirm: Stability or Increased Uncertainty on the Horizon?
Company Overview: Affirm Holdings is a key player in the buy-now-pay-later (BNPL) sector, reporting significant growth in gross merchandise volume, revenue, and net income in its recent quarterly results.
Financial Performance: The company achieved a gross merchandise volume of $13.8 billion, a 36% increase year-over-year, with revenue climbing 30% to $1.12 billion and net income rising 61% to $130 million.
Market Position and Risks: Despite strong financials, analysts express caution due to potential credit risks and competition from established players like PayPal and Klarna, as well as rising delinquency rates in the credit market.
Investment Outlook: Affirm is seen as a high-risk, high-reward investment, with analysts generally bullish on its growth potential, but investors are advised to be wary of associated risks before investing.
See More
Notice of Class Action Lawsuit for PayPal Stockholders
- Class Action Notice: Rosen Law Firm reminds investors who purchased PayPal common stock between February 25, 2025, and February 2, 2026, to apply as lead plaintiffs by April 20, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that while PayPal provided investors with optimistic financial targets for 2027, it concealed the true inefficacy of its salesforce to capitalize on growth potential, resulting in investor losses once the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first in 2017 for the number of securities class action settlements, showcasing its expertise in this field.
- Investor Action Recommendations: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, emphasizing the importance of selecting qualified legal counsel to protect their interests and avoid inexperienced intermediaries.
See More
PayPal Class Action Reminder for Investors
- Class Action Notice: Rosen Law Firm reminds investors who purchased PayPal stock between February 25, 2025, and February 2, 2026, to apply as lead plaintiffs by April 20, 2026, to participate in the class action and seek compensation.
- Fee Arrangement: Participants can receive compensation without any upfront costs through a contingency fee arrangement, which reduces the financial burden on investors and encourages more affected shareholders to join the lawsuit.
- Lawsuit Background: The lawsuit alleges that PayPal misled investors by providing overly optimistic information about its 2027 financial targets while concealing the salesforce's inability to effectively execute on its growth potential, resulting in investor losses when the truth emerged.
- Law Firm Advantage: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating its extensive experience and success in handling such cases, prompting investors to carefully select qualified legal counsel.
See More
PayPal Faces Securities Class Action Lawsuit
- Lawsuit Background: Hagens Berman has filed a securities class action lawsuit against PayPal and its executives following a surprise leadership change and the withdrawal of long-term financial targets, which has undermined investor confidence.
- Unachievable Financial Targets: The lawsuit alleges that the 2027 financial targets set in early 2025 were unattainable under existing operational constraints and required an unrealistically stable macroeconomic environment.
- Stock Price Crash: Following the announcement of CEO Alex Chriss's departure on February 3, 2026, PayPal's stock plummeted from $52.33 on February 2, 2026, to $41.70, erasing over $10 billion in shareholder value in a single day.
- Investor Action: Investors who purchased PayPal common stock during the Class Period from February 25, 2025, to February 2, 2026, must apply by April 20, 2026, to be appointed as Lead Plaintiff to recover losses.
See More
Multiple Companies Face Class Action Lawsuits
- PayPal Lawsuit Overview: PayPal Holdings, Inc. is facing allegations of overstating its business execution capabilities during the period from February 25, 2025, to February 2, 2026, which may mislead investors about the company's prospects and negatively impact stock prices and investor confidence.
- NuScale Risk Disclosure: NuScale Power Corporation is accused of failing to disclose significant risks associated with its nuclear energy projects during the period from May 13, 2025, to November 6, 2025, potentially exposing its commercialization strategy to failures and regulatory challenges, which could hinder future growth.
- Corcept FDA Concerns: Corcept Therapeutics Incorporated is alleged to have not disclosed FDA concerns regarding the adequacy of its drug effectiveness assessment from October 31, 2024, to December 30, 2025, which may lead to significant obstacles in future drug applications and damage the company's reputation.
- Navan IPO Controversy: Navan, Inc. is accused of failing to disclose a 39% increase in sales and marketing expenses during its 2025 IPO, which could mislead investors about the company's financial health and affect its market performance.
See More
Investors Should Exercise Caution with Low-Priced Stocks
- Yelp Sales Growth Weakness: Yelp (NYSE:YELP) has shown a lackluster annual growth rate of only 7.1% over the past three years, which is below the average for consumer internet companies, and projected flat sales for the next 12 months indicate a slowdown in demand that could undermine investor confidence.
- FNF Profitability Challenges: Fidelity National Financial (NYSE:FNF) has experienced a 1.6% annual contraction in net premiums over the last five years, and despite revenue growth, its earnings per share have declined by 1.3% annually, highlighting profitability pressures that may affect shareholder returns.
- Novavax Demand Plummeting: Novavax (NASDAQ:NVAX) has only achieved a 6.9% annual revenue growth over the past two years, with projected sales expected to plummet by 66.2% in the next 12 months, indicating a significant drop in vaccine demand that could lead to cash flow issues.
- Low-Priced Stock Risk Warning: While these stocks priced under $50 may seem affordable, their underlying business models and profitability are fraught with uncertainty, necessitating careful risk assessment by investors to avoid potential losses.
See More
Affirm: Stability or Increased Uncertainty on the Horizon?
Company Overview: Affirm Holdings is a key player in the buy-now-pay-later (BNPL) sector, reporting significant growth in gross merchandise volume, revenue, and net income in its recent quarterly results.
Financial Performance: The company achieved a gross merchandise volume of $13.8 billion, a 36% increase year-over-year, with revenue climbing 30% to $1.12 billion and net income rising 61% to $130 million.
Market Position and Risks: Despite strong financials, analysts express caution due to potential credit risks and competition from established players like PayPal and Klarna, as well as rising delinquency rates in the credit market.
Investment Outlook: Affirm is seen as a high-risk, high-reward investment, with analysts generally bullish on its growth potential, but investors are advised to be wary of associated risks before investing.
See More
Notice of Class Action Lawsuit for PayPal Stockholders
- Class Action Notice: Rosen Law Firm reminds investors who purchased PayPal common stock between February 25, 2025, and February 2, 2026, to apply as lead plaintiffs by April 20, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that while PayPal provided investors with optimistic financial targets for 2027, it concealed the true inefficacy of its salesforce to capitalize on growth potential, resulting in investor losses once the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first in 2017 for the number of securities class action settlements, showcasing its expertise in this field.
- Investor Action Recommendations: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, emphasizing the importance of selecting qualified legal counsel to protect their interests and avoid inexperienced intermediaries.
See More
PayPal Class Action Reminder for Investors
- Class Action Notice: Rosen Law Firm reminds investors who purchased PayPal stock between February 25, 2025, and February 2, 2026, to apply as lead plaintiffs by April 20, 2026, to participate in the class action and seek compensation.
- Fee Arrangement: Participants can receive compensation without any upfront costs through a contingency fee arrangement, which reduces the financial burden on investors and encourages more affected shareholders to join the lawsuit.
- Lawsuit Background: The lawsuit alleges that PayPal misled investors by providing overly optimistic information about its 2027 financial targets while concealing the salesforce's inability to effectively execute on its growth potential, resulting in investor losses when the truth emerged.
- Law Firm Advantage: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating its extensive experience and success in handling such cases, prompting investors to carefully select qualified legal counsel.
See More
PayPal Faces Securities Class Action Lawsuit
- Lawsuit Background: Hagens Berman has filed a securities class action lawsuit against PayPal and its executives following a surprise leadership change and the withdrawal of long-term financial targets, which has undermined investor confidence.
- Unachievable Financial Targets: The lawsuit alleges that the 2027 financial targets set in early 2025 were unattainable under existing operational constraints and required an unrealistically stable macroeconomic environment.
- Stock Price Crash: Following the announcement of CEO Alex Chriss's departure on February 3, 2026, PayPal's stock plummeted from $52.33 on February 2, 2026, to $41.70, erasing over $10 billion in shareholder value in a single day.
- Investor Action: Investors who purchased PayPal common stock during the Class Period from February 25, 2025, to February 2, 2026, must apply by April 20, 2026, to be appointed as Lead Plaintiff to recover losses.
See More
Multiple Companies Face Class Action Lawsuits
- PayPal Lawsuit Overview: PayPal Holdings, Inc. is facing allegations of overstating its business execution capabilities during the period from February 25, 2025, to February 2, 2026, which may mislead investors about the company's prospects and negatively impact stock prices and investor confidence.
- NuScale Risk Disclosure: NuScale Power Corporation is accused of failing to disclose significant risks associated with its nuclear energy projects during the period from May 13, 2025, to November 6, 2025, potentially exposing its commercialization strategy to failures and regulatory challenges, which could hinder future growth.
- Corcept FDA Concerns: Corcept Therapeutics Incorporated is alleged to have not disclosed FDA concerns regarding the adequacy of its drug effectiveness assessment from October 31, 2024, to December 30, 2025, which may lead to significant obstacles in future drug applications and damage the company's reputation.
- Navan IPO Controversy: Navan, Inc. is accused of failing to disclose a 39% increase in sales and marketing expenses during its 2025 IPO, which could mislead investors about the company's financial health and affect its market performance.
See More
Investors Should Exercise Caution with Low-Priced Stocks
- Yelp Sales Growth Weakness: Yelp (NYSE:YELP) has shown a lackluster annual growth rate of only 7.1% over the past three years, which is below the average for consumer internet companies, and projected flat sales for the next 12 months indicate a slowdown in demand that could undermine investor confidence.
- FNF Profitability Challenges: Fidelity National Financial (NYSE:FNF) has experienced a 1.6% annual contraction in net premiums over the last five years, and despite revenue growth, its earnings per share have declined by 1.3% annually, highlighting profitability pressures that may affect shareholder returns.
- Novavax Demand Plummeting: Novavax (NASDAQ:NVAX) has only achieved a 6.9% annual revenue growth over the past two years, with projected sales expected to plummet by 66.2% in the next 12 months, indicating a significant drop in vaccine demand that could lead to cash flow issues.
- Low-Priced Stock Risk Warning: While these stocks priced under $50 may seem affordable, their underlying business models and profitability are fraught with uncertainty, necessitating careful risk assessment by investors to avoid potential losses.
See More
